Average Co-Inventor Count = 11.92
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (8 from 832,843 patents)
2. Elan Pharmaceuticals, Inc. (6 from 202 patents)
3. Imago Pharmaceuticals, Inc. (3 from 5 patents)
4. Eli Lilly and Company (2 from 4,446 patents)
5. Athena Neurosciences, Inc. (2 from 35 patents)
19 patents:
1. 9884828 - Substituted cinnolines as inhibitors of LRRK2 kinase activity
2. 9796706 - Inhibitors of Jun N-terminal kinase
3. 9073891 - Inhibitors of Jun N-terminal kinase
4. 8541418 - Inhibitors of polo-like kinase
5. 8450363 - Inhibitors of Jun N-terminal kinase
6. 8445503 - Inhibitors of polo-like kinase
7. 7906556 - Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
8. 7432379 - [object Object]
9. 7417152 - [object Object]
10. 7153847 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
12. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use
13. 6667305 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
14. 6653303 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
15. 6635632 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds